SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
This additional acquisition in Spain market increases DESMA Spain’s footprint and business.
SIT Group takes part in the international exhibition of the pharmaceutical world: CPhI Worldwide from 24 to 26 october 2023 in Barcelona, Spain, stand 2N30.
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
SIT Group is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL as a result of the agreement signed on October 25th, 2022.